| Primary brain tumours in adults S Lapointe, A Perry, NA Butowski The Lancet 392 (10145), 432-446, 2018 | 1180 | 2018 |
| Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma TF Cloughesy, AY Mochizuki, JR Orpilla, W Hugo, AH Lee, TB Davidson, ... Nature medicine 25 (3), 477-486, 2019 | 1163 | 2019 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The lancet oncology 18 (10), 1373-1385, 2017 | 991 | 2017 |
| Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study N Butowski, H Colman, JF De Groot, AM Omuro, L Nayak, PY Wen, ... Neuro-oncology 18 (4), 557-564, 2015 | 529 | 2015 |
| Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed … AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ... JAMA oncology 6 (4), 495-503, 2020 | 454 | 2020 |
| Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma MD Prados, SM Chang, N Butowski, R DeBoer, R Parvataneni, H Carliner, ... Journal of Clinical Oncology 27 (4), 579-584, 2009 | 437 | 2009 |
| Recent advances in therapy for glioblastoma J Clarke, N Butowski, S Chang Archives of neurology 67 (3), 279-283, 2010 | 367 | 2010 |
| Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology LB Nabors, J Portnow, M Ahluwalia, J Baehring, H Brem, S Brem, ... Journal of the National Comprehensive Cancer Network 18 (11), 1537-1570, 2020 | 365 | 2020 |
| Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors I Krop, T Demuth, T Guthrie, PY Wen, WP Mason, P Chinnaiyan, ... Journal of clinical oncology 30 (19), 2307-2313, 2012 | 351 | 2012 |
| Preoperative prognostic classification system for hemispheric low-grade gliomas in adults EF Chang, JS Smith, SM Chang, KR Lamborn, MD Prados, N Butowski, ... Journal of neurosurgery 109 (5), 817-824, 2008 | 257 | 2008 |
| Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma MD Prados, KR Lamborn, S Chang, E Burton, N Butowski, M Malec, ... Neuro-oncology 8 (1), 67-78, 2006 | 254 | 2006 |
| Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized … A Omuro, AA Brandes, AF Carpentier, A Idbaih, DA Reardon, ... Neuro-oncology 25 (1), 123-134, 2023 | 249 | 2023 |
| Diagnosis and treatment of recurrent high-grade astrocytoma NA Butowski, PK Sneed, SM Chang Journal of clinical oncology 24 (8), 1273-1280, 2006 | 249 | 2006 |
| Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial O Bloch, CA Crane, Y Fuks, R Kaur, MK Aghi, MS Berger, NA Butowski, ... Neuro-oncology 16 (2), 274-279, 2014 | 241 | 2014 |
| Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02) FM Iwamoto, KR Lamborn, HI Robins, MP Mehta, SM Chang, ... Neuro-oncology 12 (8), 855-861, 2010 | 236 | 2010 |
| Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy CN Kline, NM Joseph, JP Grenert, J van Ziffle, E Talevich, C Onodera, ... Neuro-oncology 19 (5), 699-709, 2017 | 233 | 2017 |
| Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein CA Crane, SJ Han, B Ahn, J Oehlke, V Kivett, A Fedoroff, N Butowski, ... Clinical cancer research 19 (1), 205-214, 2013 | 195 | 2013 |
| NCCN guidelines insights: central nervous system cancers, version 1.2017 LB Nabors, J Portnow, M Ammirati, J Baehring, H Brem, N Butowski, ... Journal of the National Comprehensive Cancer Network 15 (11), 1331-1345, 2017 | 186 | 2017 |
| Central nervous system cancers LB Nabors, M Ammirati, PJ Bierman, H Brem, N Butowski, ... Journal of the National Comprehensive Cancer Network 11 (9), 1114-1151, 2013 | 180 | 2013 |
| Clinical practice experience with NovoTTF-100A™ system for glioblastoma: the Patient Registry Dataset (PRiDe) MM Mrugala, HH Engelhard, DD Tran, Y Kew, R Cavaliere, JL Villano, ... Seminars in oncology 41, S4-S13, 2014 | 154 | 2014 |
